Semax and Selank come up together in laboratory catalogs so often that many buyers treat them as interchangeable line items. They are not. Both are short synthetic peptides carrying the same C-terminal Pro-Gly-Pro extension, and both are handled in the lab in broadly similar ways. Their parent sequences, however, are unrelated, and the preclinical literature around each has developed along different lines.
A researcher comparing Semax vs Selank is usually asking two questions at once. The first is scientific: what mechanistic territory does each peptide occupy in published in-vitro and animal-model work. The second is documentary: do the two differ in their stability characteristics, storage requirements, or analytical documentation, and what should a certificate of analysis show before material enters a study.
The sections below address both, qualitatively on the science and in practical detail on the bench work, since sourcing and handling errors account for far more failed experiments with short peptides than any subtlety of mechanism.
What Semax Is
Semax is a synthetic peptide built from a fragment of adrenocorticotropic hormone, commonly written as ACTH, joined to a Pro-Gly-Pro tail. The ACTH-derived portion is the segment associated in the older literature with non-hormonal activity, meaning the part of the parent molecule that was studied separately from the steroidogenic signaling that ACTH is best known for. Appending Pro-Gly-Pro was a deliberate design choice intended to slow enzymatic degradation of a sequence that would otherwise be cleared very quickly in biological matrices.
Structurally, Semax is a short, highly polar, water-soluble peptide with no disulfide bridges and no lipid modification. It contains a methionine residue, which is the single most important handling detail for anyone planning long-term storage or repeated solution work. Methionine is oxidation-prone, and oxidized Semax appears as a distinct, slightly shifted peak in reversed-phase HPLC traces.
In preclinical work, Semax has been examined largely in the context of neurotrophin signaling, with in-vitro and animal-model studies reporting changes in brain-derived neurotrophic factor expression and in downstream receptor-associated pathways. Related lines of investigation have looked at gene expression patterns in neural tissue models and at models of restricted blood flow in nervous tissue. All of that work is exploratory.
What Selank Is
Selank is a synthetic analog of tuftsin, an endogenous peptide fragment derived from immunoglobulin G. As with Semax, the native sequence has been extended with Pro-Gly-Pro to improve stability against peptidases. The parent relationship matters, because tuftsin biology sits at the intersection of immune and neural signaling, and the Selank literature reflects that dual heritage.
Selank is likewise short, polar, and freely water-soluble. Basic residues give the molecule a net positive charge across most working buffer ranges, with practical consequences for ion-exchange behavior and for adsorption onto glass and certain plastics. Unlike Semax, Selank has no methionine, so the oxidation liability that dominates Semax handling is absent.
The preclinical literature on Selank clusters around stress-response behavioral models in rodents, around GABAergic and serotonergic signaling markers, and around immune-neural crosstalk consistent with its tuftsin derivation. Every one of those descriptions summarizes exploratory model work, not a statement about what the compound does in a person.
How Their Research Contexts Differ
The most useful way to frame the difference is by parent molecule. Semax descends from a stress-axis hormone fragment and has been studied predominantly in neurotrophin signaling research and in models of neural tissue insult. Selank descends from an immune-derived peptide and has been studied predominantly in neuropeptide signaling research touching stress-response behavioral models and immune-neural interaction.
Overlap does exist. Both peptides appear in studies of regulatory peptide metabolism, both have been examined for effects on gene expression profiles in neural tissue, and both are frequently cited in the same reviews because of their shared design lineage. A study design that treats them as two probes of related but distinct signaling territory is defensible. A design that treats them as two versions of the same thing is not.
The table below compares the two on qualitative attributes only. No potency or outcome figures appear, because published work across different models and assay formats does not support that kind of side-by-side numeric claim.
Attribute | Semax | Selank |
|---|---|---|
Derivation and parent sequence | Fragment of adrenocorticotropic hormone with a Pro-Gly-Pro extension | Analog of the endogenous peptide tuftsin with a Pro-Gly-Pro extension |
Structural class | Short linear synthetic peptide, no disulfide bridges, highly polar | Short linear synthetic peptide, no disulfide bridges, highly polar and basic |
Primary research contexts in the literature | Neurotrophin expression models, neural gene expression profiling, models of restricted blood flow in nervous tissue | Stress-response behavioral models, inhibitory neurotransmitter signaling markers, immune-neural crosstalk |
Notable chemical liability | Methionine residue makes oxidation the dominant degradation route | No methionine; hydrolysis and surface adsorption are the more relevant concerns |
Solubility behavior | Readily soluble in aqueous buffer without organic cosolvent | Readily soluble in aqueous buffer without organic cosolvent |
Stability characteristics | Supplied lyophilized; light-sensitive and susceptible to oxidation. Follow batch-specific documentation and validated laboratory procedures. | Supplied lyophilized; net positive charge associated with adsorptive loss on standard labware. Follow batch-specific documentation and validated laboratory procedures. |
Typical assay settings | Neuronal and glial cell culture, tissue slice preparations, rodent model work | Rodent behavioral paradigms, immune cell culture, enzyme activity preparations |
Documentation expectations | RP-HPLC purity trace, molecular weight confirmation, net peptide content, water content | RP-HPLC purity trace, molecular weight confirmation, net peptide content, water content |
Reading a Certificate of Analysis for Either Peptide
A usable certificate names the compound and its sequence, states the analytical methods used, gives a lot or batch identifier, and reports a date. Anything missing the batch identifier is not traceable and should be treated as marketing collateral rather than documentation. For both Semax and Selank, expect a reversed-phase HPLC chromatogram rather than a bare numeric summary. The trace itself is the evidence. A single sharp main peak with a flat baseline tells a different story than a main peak flanked by a cluster of partially resolved shoulders, even when both are summarized identically in the text of the certificate.
Expect an identity result from MS analysis alongside the purity trace. Purity and identity answer different questions, and a certificate that reports only one of them is incomplete. Water content by Karl Fischer titration or by loss on drying is a valuable third element, since residual moisture in a lyophilized cake affects both storage stability and the accuracy of any weight-based calculation the lab performs later.
For Semax specifically, look at whether the chromatogram shows an early-eluting shoulder consistent with methionine oxidation. Oxidized species are more polar and generally elute ahead of the parent peak. Their presence in a fresh lot says something about how the material was processed and stored before it reached you.
Chromatographic Purity Versus Net Peptide Content
The single most common misreading of peptide documentation is treating chromatographic purity as though it described the whole contents of the vial. It does not. Chromatographic purity describes the proportion of peptide-related material that corresponds to the target sequence. Net peptide content describes how much of the total dry weight in the vial is actually peptide at all.
The remainder of that dry weight is typically counterion, most often trifluoroacetate from the purification step, plus residual water and any bulking salt. A lot can show high chromatographic purity and still have a meaningful share of its weight taken up by non-peptide material. Both figures are legitimate; they simply answer different questions.
The practical consequence is identical for Semax and Selank. Where net peptide content is not accounted for, the actual concentration of a solution sits below its nominal value, and that offset differs from lot to lot. Amino acid analysis is the reference method here. Labs that switch lots mid-study and see an unexplained shift in response are very often looking at a net peptide content difference rather than a biological effect.
Identity Confirmation and Molecular Weight Verification
Identity for short synthetic peptides rests primarily on molecular weight confirmation by MS analysis, usually electrospray ionization or matrix-assisted laser desorption ionization coupled to a time-of-flight analyzer. The observed value is compared against the value calculated from the stated sequence. Agreement within instrument tolerance supports identity; a discrepancy is a stop condition.
Molecular weight alone does not resolve every ambiguity, since sequence isomers and certain substitutions produce near-identical weights. A lab with a strict identity requirement will ask for tandem MS fragmentation data as well. For routine research use, an intact molecular weight result plus a clean RP-HPLC trace is the normal standard for both peptides.
Common deviations include deletion sequences from incomplete coupling during solid-phase peptide synthesis, which appear at lower weight, and adducts or oxidation products, which appear higher. For Semax, an increment consistent with a single added oxygen atom is the classic oxidized-methionine signature.
Lyophilized Form and Solubility Characteristics
Both peptides are supplied lyophilized because short peptides in aqueous solution degrade steadily through hydrolysis, oxidation, and microbial growth, while a dry cake held cold is stable for far longer. Lyophilization also produces a porous structure that dissolves rapidly on contact with solvent.
Both Semax and Selank are readily soluble in aqueous media, and neither normally requires an organic cosolvent such as acetonitrile or dimethyl sulfoxide, which distinguishes them from more hydrophobic peptides. Solubility, solvent compatibility, and solution stability for a given lot should be evaluated according to the laboratory's validated methods, following institutional procedures and the batch-specific storage and handling documentation supplied with the material.
The two compounds differ in two material properties worth noting. Selank has a net positive charge and can adsorb onto glass and untreated polypropylene, particularly at low concentration. Semax is less prone to that behavior but carries an oxidation liability associated with its methionine content and is sensitive to light.
Storage Requirements and Solution Stability
Lyophilized material for both compounds is normally held at -20 degrees C, with long-term inventory sometimes kept colder. Short transit at ambient temperature is generally tolerated by dry peptide. Solution stability may differ substantially from dry-state stability and can depend on the solvent, container material, temperature, and study conditions.
Repeated freeze-thaw cycling is a known degradation pathway for peptides in solution: it drives aggregation, concentrates solutes at the ice interface, and shifts local pH as buffer components crystallize at different rates. Degradation of this kind accumulates without visible change, since the solution stays clear while intact peptide content declines. Laboratories should rely on validated internal procedures and available batch-specific stability documentation rather than general preparation instructions.
Endotoxin and Sterility Testing
Bacterial endotoxin is the contaminant most likely to confound work with either peptide, and the relevance is greatest for Selank given the immune-signaling context much of its literature sits in. Endotoxin activates innate immune pathways at very low levels, and a cytokine readout contaminated by endotoxin can resemble a peptide effect. Where endotoxin is relevant to the intended laboratory work, the applicable lot-specific LAL test result is the relevant documentation to review.
Sterility is a separate quality attribute, established through different testing methods. Microbial growth in an aqueous peptide solution consumes the peptide and introduces metabolites that interfere with detection. Where either attribute is relevant, researchers should review the applicable lot-specific test results and follow their institution's validated procedures.
Supplier Evaluation and Sourcing
Supplier evaluation for these two peptides follows the same logic as for any research-grade material, with a few compound-specific points. Ask for the batch-specific certificate of analysis before purchase, not a generic example document. Confirm that the certificate carries both an RP-HPLC purity trace and a molecular weight confirmation, and that the lot number on the certificate matches the label on the vial you receive.
Ask whether net peptide content is reported and by what method, how material is stored and shipped, and whether third-party analytical results exist for the specific lot rather than for a historical batch. A supplier that answers plainly and provides the underlying chromatograms is behaving like a materials vendor. One that answers with adjectives is not.
Labs sourcing this class of compound can review batch documentation on a vendor product page before committing; the Semax research peptide listing from Bluum Peptides is an example of the kind of listing where lot-level analytical paperwork should be available on request. Apply the same document standard to Selank or to any other short synthetic peptide entering the same study.
Finally, watch for consistency across reorders. A supplier whose chromatograms look materially different from lot to lot is telling you something about their upstream synthesis, even when each individual lot passes.
Frequently Asked Questions
What is Semax?
Semax is a short synthetic peptide derived from a fragment of adrenocorticotropic hormone, extended at the C-terminus with a Pro-Gly-Pro sequence that slows enzymatic breakdown. It is supplied lyophilized as a research chemical.
In preclinical work it has been investigated mainly in the context of neurotrophin signaling and neural gene expression models. Those investigations are exploratory and do not establish any outcome outside a controlled research setting.
What is Selank?
Selank is a synthetic analog of tuftsin, an endogenous peptide fragment derived from immunoglobulin G, likewise extended with a Pro-Gly-Pro tail for stability. It is also supplied lyophilized for laboratory use.
The published preclinical literature has explored Selank in rodent stress-response behavioral models, in relation to inhibitory neurotransmitter signaling markers, and in immune-neural crosstalk consistent with its tuftsin origin.
How do the research applications of Semax vs Selank differ?
The difference traces back to their parent sequences. Semax work concentrates on neurotrophin expression and neural tissue models, while Selank work concentrates on stress-response behavioral paradigms and immune-neural signaling.
They are not substitutes for one another in study design. Treat them as probes of related but distinct signaling territory, and describe results in terms of the specific model used rather than as general properties of either compound.
What differences matter when Semax and Selank appear in the same research program?
The suitability of either peptide for a particular in-vitro model depends on the laboratory's validated study design, controls, materials, and analytical methods. Experimental procedures should be established by qualified laboratory personnel under the applicable institutional protocols.
As a matter of material properties, Selank is more prone to adsorptive loss on standard labware because of its net positive charge, and Semax carries an oxidation liability that Selank does not. Both properties are documented characteristics of the compounds rather than features of any particular method.
What are the storage requirements for each peptide?
Follow the storage conditions stated on the product label, batch documentation, and supplier materials. Both compounds are normally supplied lyophilized for storage at -20 degrees C, protected from light and moisture, and should be maintained in a controlled laboratory environment under the conditions specified for the applicable lot.
Solution stability may differ from dry-state stability and can depend on the solvent, container material, temperature, and study conditions. Laboratories should rely on validated internal procedures and available batch-specific stability documentation.
Are Semax or Selank approved for human use?
No. Both compounds are offered strictly as research chemicals for laboratory investigation. Neither is intended for human or veterinary administration, and nothing in the preclinical literature described here should be read as support for any use in people.
Disclaimer: All compounds discussed in this article, including any products referenced, are intended strictly for laboratory research use only. They are not for human or veterinary use, not for diagnostic or therapeutic purposes, and nothing in this article should be read as guidance for any application outside a controlled research setting.
